VEXPX | VWYKX | VEXPX / VWYKX | |
Total Expense Ratio | 0.44 | 1.01 | 44% |
Annual Report Gross Expense Ratio | 0.44 | 1.01 | 44% |
Fund Existence | 58 years | 3 years | - |
Gain YTD | -0.278 | -3.300 | 8% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 1000 | 300% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.1B | 1.4B | 1,437% |
Annual Yield % from dividends | 0.40 | 1.74 | 23% |
Returns for 1 year | -1.74 | -8.28 | 21% |
Returns for 3 years | 20.08 | N/A | - |
Returns for 5 years | 11.75 | N/A | - |
Returns for 10 years | 15.27 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 16.23 | 0.50 | +3.18% |
ProShares UltraShort Nasdaq Biotech | |||
FAPR | 42.35 | -0.02 | -0.05% |
FT Vest US Equity Buffer ETF Apr | |||
FXE | 107.85 | -0.06 | -0.06% |
Invesco CurrencyShares® Euro Currency | |||
IEF | 94.32 | -0.44 | -0.46% |
iShares 7-10 Year Treasury Bond ETF | |||
FMED | 23.80 | -0.38 | -1.58% |
Fidelity Disruptive Medicine ETF |